CPRX vs FTI
CATALYST PHARMACEUTICALS, INC. vs TechnipFMC plc — Side-by-Side Stock Comparison
CPRX
CATALYST PHARMACEUTICALS, INC.
6.4
Consider Buy
$24.83
FTI
TechnipFMC plc
8.5
Strong Buy
$69.81
CPRX vs FTI: Which is the Better Investment?
CATALYST PHARMACEUTICALS, INC. (CPRX) scores 6.4/10 while TechnipFMC plc (FTI) scores 8.5/10 on AlphaStocks' composite model. TechnipFMC plc has the higher composite rating of Strong Buy. On a P/E basis, CATALYST PHARMACEUTICALS, INC. trades at 14.7x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | CPRX | FTI |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.4/10 | 8.5/10▲ |
| Rating | Consider Buy | Strong Buy▲ |
| Price | $24.83 | $69.81 |
| P/E Ratio | 14.7▲ | 30.4 |
| ROE | 22.9% | 28.8%▲ |
| Market Cap | $3B | $29B |
| Fair Value | — | $48.94 |
| Dividend Yield | — | — |
| Sector Rank | #197 of 1127 | #2 of 1127▲ |
| Model Verdicts | ||
| Piotroski | Neutral | Strong▲ |
| Buffett | Attractive | Strong▲ |
| Graham | Neutral▲ | Caution |
| Lynch | Strong | Strong |
| Greenblatt | Limited Data | Neutral▲ |
CPRX vs FTI: Which Stock Scores Higher?
CATALYST PHARMACEUTICALS, INC. (CPRX) and TechnipFMC plc (FTI) are among the most compared stocks in the S&P 500. FTI currently leads with a composite score of 8.5/10 (Strong Buy) compared to CPRX's 6.4/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer